Is fibrinolysis critical for acute coronary syndromes?
Kluft
C
C
The Gaubius Laboratory, TNO Institute for Prevention and Health, Leiden, The Netherlands,
Andreotti
F
F
D000208:Acute Disease; D001777:Blood Coagulation / Q000187:drug effects / Q000502:physiology; D003327:Coronary Disease / Q000097:blood / Q000150:complications / Q000188:drug therapy*; D005343:Fibrinolytic Agents / Q000627:therapeutic use*; D006439:Hemodynamics / Q000187:drug effects / Q000502:physiology; D006801:Humans; D009203:Myocardial Infarction / Q000097:blood / Q000209:etiology; D013577:Syndrome; D010959:Tissue Plasminogen Activator / Q000009:adverse effects / Q000097:blood; D017211:Treatment Failure
D005343:Fibrinolytic Agents; D010959:Tissue Plasminogen Activator